102 related articles for article (PubMed ID: 27324042)
1. Functional Basis and Biophysical Approaches to Characterize the C-Terminal Domain of Human-Ribosomal S6 Kinases-3.
Jagilinki BP; Choudhary RK; Thapa PS; Gadewal N; Hosur MV; Kumar S; Varma AK
Cell Biochem Biophys; 2016 Sep; 74(3):317-25. PubMed ID: 27324042
[TBL] [Abstract][Full Text] [Related]
2. ERK and RSK regulate distinct steps of a cellular program that induces transition from multicellular epithelium to single cell phenotype.
Čáslavský J; Klímová Z; Vomastek T
Cell Signal; 2013 Dec; 25(12):2743-51. PubMed ID: 24012955
[TBL] [Abstract][Full Text] [Related]
3. The RSK family of kinases: emerging roles in cellular signalling.
Anjum R; Blenis J
Nat Rev Mol Cell Biol; 2008 Oct; 9(10):747-58. PubMed ID: 18813292
[TBL] [Abstract][Full Text] [Related]
4. Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases.
Fruergaard MU; Nielsen CJF; Kjeldsen CR; Iversen L; Andersen JL; Nissen P
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36806093
[TBL] [Abstract][Full Text] [Related]
5. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the autoinhibition of the C-terminal kinase domain of human RSK1.
Li D; Fu TM; Nan J; Liu C; Li LF; Su XD
Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):680-5. PubMed ID: 22683790
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.
Yang TT; Xiong Q; Graef IA; Crabtree GR; Chow CW
Mol Cell Biol; 2005 Feb; 25(3):907-20. PubMed ID: 15657420
[TBL] [Abstract][Full Text] [Related]
8. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
9. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
[TBL] [Abstract][Full Text] [Related]
10. Dynamic control of RSK complexes by phosphoswitch-based regulation.
Gógl G; Biri-Kovács B; Póti ÁL; Vadászi H; Szeder B; Bodor A; Schlosser G; Ács A; Turiák L; Buday L; Alexa A; Nyitray L; Reményi A
FEBS J; 2018 Jan; 285(1):46-71. PubMed ID: 29083550
[TBL] [Abstract][Full Text] [Related]
11. Regulation and function of the RSK family of protein kinases.
Romeo Y; Zhang X; Roux PP
Biochem J; 2012 Jan; 441(2):553-69. PubMed ID: 22187936
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.
Gógl G; Alexa A; Kiss B; Katona G; Kovács M; Bodor A; Reményi A; Nyitray L
J Biol Chem; 2016 Jan; 291(1):11-27. PubMed ID: 26527685
[TBL] [Abstract][Full Text] [Related]
13. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling.
Lopez J; Bonsor DA; Sale MJ; Urisman A; Mehalko JL; Cabanski-Dunning M; Castel P; Simanshu DK; McCormick F
J Biol Chem; 2023 Jun; 299(6):104789. PubMed ID: 37149146
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
Ikuta M; Kornienko M; Byrne N; Reid JC; Mizuarai S; Kotani H; Munshi SK
Protein Sci; 2007 Dec; 16(12):2626-35. PubMed ID: 17965187
[TBL] [Abstract][Full Text] [Related]
15. Light- and clock-dependent regulation of ribosomal S6 kinase activity in the suprachiasmatic nucleus.
Butcher GQ; Lee B; Hsieh F; Obrietan K
Eur J Neurosci; 2004 Feb; 19(4):907-15. PubMed ID: 15009138
[TBL] [Abstract][Full Text] [Related]
16. Identification of RSK substrates using an analog-sensitive kinase approach.
Lizcano-Perret B; Vertommen D; Herinckx G; Calabrese V; Gatto L; Roux PP; Michiels T
J Biol Chem; 2024 Mar; 300(3):105739. PubMed ID: 38342435
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
Burkhard KA; Chen F; Shapiro P
J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.
Dümmler BA; Hauge C; Silber J; Yntema HG; Kruse LS; Kofoed B; Hemmings BA; Alessi DR; Frödin M
J Biol Chem; 2005 Apr; 280(14):13304-14. PubMed ID: 15632195
[TBL] [Abstract][Full Text] [Related]
19. Selective Targeting of RSK Isoforms in Cancer.
Casalvieri KA; Matheson CJ; Backos DS; Reigan P
Trends Cancer; 2017 Apr; 3(4):302-312. PubMed ID: 28718440
[TBL] [Abstract][Full Text] [Related]
20. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.
Richards SA; Dreisbach VC; Murphy LO; Blenis J
Mol Cell Biol; 2001 Nov; 21(21):7470-80. PubMed ID: 11585927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
